Modern Diagnostics & Nursing Home Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 09-01-2025
- Paid Up Capital ₹ 1.45 Cr
as on 09-01-2025
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.71 Cr
as on 09-01-2025
- Revenue %
(FY 2022)
- Profit 84931.19%
(FY 2022)
- Ebitda 129508.16%
(FY 2022)
- Net Worth 1826.62%
(FY 2022)
- Total Assets 2327.49%
(FY 2022)
About Modern Diagnostics & Nursing Home
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.45 Cr.
The company currently has active open charges totaling ₹1.71 Cr.
Avidip De, Mallika De, Gouri De, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300WB2021PTC244030
- Company No.
244030
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2021
- Date of AGM
10 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Birbhum, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Modern Diagnostics & Nursing Home?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avidip De  | Director | 20-Mar-2021 | Current |
| Mallika De | Director | 20-Mar-2021 | Current |
| Gouri De | Director | 20-Mar-2021 | Current |
| Avisek De | Director | 20-Mar-2021 | Current |
Financial Performance of Modern Diagnostics & Nursing Home.
Modern Diagnostics & Nursing Home Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 84931.19% increase in profit. The company's net worth Soared by an impressive increase of 1826.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Modern Diagnostics & Nursing Home?
In 2021, Modern Diagnostics & Nursing Home had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.71 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 1.71 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2024 | Bank Of India | ₹3.12 M | Open |
| 29 Dec 2023 | Bank Of India | ₹1.40 Cr | Open |
How Many Employees Work at Modern Diagnostics & Nursing Home?
Modern Diagnostics & Nursing Home has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Modern Diagnostics & Nursing Home, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Modern Diagnostics & Nursing Home's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.